In recent years, public health research has focused on nicotine alternatives to tobacco. While the focus has traditionally been on e-cigarettes, a growing number of studies are exploring whether oral, smokeless, and non-combustion products like nicotine pouches can help users of traditional cigarettes who want to quit. Recently, several US research teams have published reports suggesting that nicotine pouches, under certain conditions, may help some tobacco users reduce their dependence on cigarettes, or even quit completely. However, they emphasize that the long-term safety of these products is insufficiently documented and warrants further investigation.
In these studies, researchers typically recruit existing smokers and encourage them to try nicotine pouches. In one study, participants used nicotine pouches at low to medium doses (e.g., 3mg or 6mg pouches) for four weeks. Results showed that these users significantly reduced their number of cigarettes. Researchers have documented that a significant number of people who use nicotine pouches have reduced their cigarette use by half or more. Others report that, while they haven’t completely quit smoking, they feel their smoking habit has been disrupted and they desire to cut back. These results are seen as a promising sign in the public health community, as tar, carbon monoxide, and other substances produced by cigarette combustion are considered the primary cause of many tobacco-related diseases.
Official agencies are also analyzing these study findings. For example, the US Centers for Disease Control and Prevention (CDC) cautions that while nicotine pouches don’t involve combustion or smoke inhalation, and may pose significantly less direct respiratory damage than cigarettes, this doesn’t mean these products are “safe.” Nicotine itself is a highly addictive substance that affects the cardiovascular system and may also cause irritation to the mouth, gums, and gastrointestinal tract, among other adverse reactions. For sensitive groups such as non-smokers, young people, and pregnant women, using any nicotine-containing product carries risks. The CDC also notes that nicotine pouches are not currently FDA-approved as smoking cessation products (e.g., for pharmaceutical purposes), although some products have been approved for marketing through pre-market approval (PMTA) or other legal pathways.
Against this backdrop, another study conducted a more detailed investigation into the perceptions, safety, and actual effectiveness of nicotine pouches. In this study, approximately 40% of users reported “successful cessation” or at least a pause in cigarette use, nearly 40% reported partial success (reducing but not completely quitting), and the remaining approximately 20% reported no significant effect. Side effects were mostly mild, such as oral irritation, dry throat, and mild gastrointestinal discomfort, typically occurring in the early stages of use. The researchers noted that the sample size and duration of use were limited, and large, long-term, and well-controlled studies are needed to examine long-term use, the effects on cardiopulmonary function, and demographic differences (e.g., age and underlying health conditions).
On a public policy level, the FDA recently authorized the marketing of some nicotine pouch products, stating that these products may be less harmful than continued combustion cigarettes for adult smokers if they meet specific criteria. Take the Zyn brand, for example. Several of its nicotine pouch products have passed the PMTA pathway and are now eligible for marketing. The FDA’s assessment considered the overall public health benefit-risk balance of these products, including the potential for harm reduction for smokers and the risk of attracting minors.
Amid these research and policy trends, an e-cigarette brand that can achieve compliance, safety, and transparency in the e-cigarette and nicotine replacement product sectors may gain stronger credibility and competitiveness in the future market. Here, we will consider the brand GUUTUU (GUUTUU e-cigarettes), a relatively new e-cigarette manufacturer/wholesale, to discuss its potential strengths and how it can excel in the context of nicotine pouch research and smoking cessation.
The positive potential of the GUUTUU e-cigarette brand lies primarily in its scale and product diversity as a wholesale e-cigarette manufacturer. According to its official website, it specializes in a variety of e-cigarette products, including disposable e-cigarettes and high-capacity e-cigarettes with adjustable airflow. A broad product line may mean it has the ability to adjust product designs and specifications to meet regulatory requirements and safety standards in different countries/regions.
Secondly, if GUUTUU invests sufficient resources in product development and quality control, it could implement the following, which are considered good practices in public health research and regulation: clearly label nicotine concentrations within products and keep them within reasonable limits; offer nicotine-free versions for consumers seeking to reduce or eliminate nicotine dependence; include comprehensive warning labels on packaging and labeling, avoiding visual designs or flavors that may appeal to minors; avoid exaggerated promises and misleading claims in advertising; and restrict sales to legal channels, performing age verification, and limiting access to e-cigarettes and related products by minors.
Furthermore, if GUUTUU prioritizes user safety, such as using reliable batteries and electronic components to prevent risks such as leakage, explosion, and overheating; providing cleaning and maintenance recommendations; noting potential side effects and recommended and unsuitable users in product instructions; and providing customer service to address health and safety concerns, these practices would enhance brand credibility and potentially reduce the risks of use.
Back to the context of the study’s findings, if GUUTUU could participate in similar studies or provide its own products for comparative testing (for example, comparing e-cigarettes with nicotine pouches), it could help accelerate the development of evidence in the public health field. If GUUTUU can establish that its e-cigarette products have positive effects in reducing daily cigarette consumption, improving respiratory function, and reducing exposure to toxic substances in smoke, and that the nicotine and other chemical components contained in them are stable and controllable, then these could be considered positive aspects.
Nevertheless, the study also highlights important uncertainties in safety. While nicotine pouches don’t involve combustion, and their smoke doesn’t contain tar and many known carcinogenic chemicals directly associated with smoking, the nicotine itself still poses potential risks to the cardiovascular system, oral mucosa, gums, and other areas. Long-term use may lead to increased heart rate, blood pressure, and impaired vascular function. In young people, nicotine can affect brain development, attention, learning ability, and impulse control. Use by pregnant women may also have adverse effects on fetal development. Many studies have limited sample duration, making it difficult to reveal these long-term or low-frequency side effects.
Another issue is whether users can completely break free from cigarette dependence, even if the product itself is safer or relatively harm-reducing. Many studies have found widespread “dual use,” where users simultaneously smoke cigarettes and use nicotine pouches or e-cigarettes, but the health risks of cigarettes are not completely eliminated.
In public health policy and clinical recommendations, researchers and regulators generally do not recommend nicotine pouches as a first-line treatment, preferring clinically proven, approved alternative therapies for smoking cessation (such as nicotine patches, nicotine gum, and other medications supplemented with behavioral therapy). Nicotine pouches may be considered a supplementary option, potentially helping adult smokers who have failed traditional methods or struggle to adhere to them.
Considering the GUUTUU brand, if it can collaborate with public health agencies, for example, by participating in clinical research, disclosing its product ingredients and test results, complying with laws and regulations, and maintaining high standards of transparency in providing e-cigarettes or nicotine-containing electronic alternative products, it could play a positive and constructive role in this area.
Tags: ceramic atomizer core, e‑hookah (electronic water pipe), flavored vape,guutuu vape.